Literature DB >> 29472712

Direct effects of thyroid hormones on hepatic lipid metabolism.

Rohit A Sinha1,2, Brijesh K Singh1, Paul M Yen1.   

Abstract

It has been known for a long time that thyroid hormones have prominent effects on hepatic fatty acid and cholesterol synthesis and metabolism. Indeed, hypothyroidism has been associated with increased serum levels of triglycerides and cholesterol as well as non-alcoholic fatty liver disease (NAFLD). Advances in areas such as cell imaging, autophagy and metabolomics have generated a more detailed and comprehensive picture of thyroid-hormone-mediated regulation of hepatic lipid metabolism at the molecular level. In this Review, we describe and summarize the key features of direct thyroid hormone regulation of lipogenesis, fatty acid β-oxidation, cholesterol synthesis and the reverse cholesterol transport pathway in normal and altered thyroid hormone states. Thyroid hormone mediates these effects at the transcriptional and post-translational levels and via autophagy. Given these potentially beneficial effects on lipid metabolism, it is possible that thyroid hormone analogues and/or mimetics might be useful for the treatment of metabolic diseases involving the liver, such as hypercholesterolaemia and NAFLD.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29472712      PMCID: PMC6013028          DOI: 10.1038/nrendo.2018.10

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


  156 in total

1.  NCoR1 and SMRT play unique roles in thyroid hormone action in vivo.

Authors:  Hiroaki Shimizu; Inna Astapova; Felix Ye; Martin Bilban; Ronald N Cohen; Anthony N Hollenberg
Journal:  Mol Cell Biol       Date:  2014-11-24       Impact factor: 4.272

2.  Effect of thyroid hormone on hepatic cholesterol 7 alpha hydroxylase, LDL receptor, HMG-CoA reductase, farnesyl pyrophosphate synthetase and apolipoprotein A-I mRNA levels in hypophysectomized rats.

Authors:  G C Ness; L C Pendleton; Y C Li; J Y Chiang
Journal:  Biochem Biophys Res Commun       Date:  1990-11-15       Impact factor: 3.575

3.  Non-receptor-mediated actions are responsible for the lipid-lowering effects of iodothyronines in FaO rat hepatoma cells.

Authors:  Elena Grasselli; Adriana Voci; Laura Canesi; Fernando Goglia; Silvia Ravera; Isabella Panfoli; Gabriella Gallo; Laura Vergani
Journal:  J Endocrinol       Date:  2011-04-20       Impact factor: 4.286

4.  The thyroid hormone receptor-beta-selective agonist GC-1 differentially affects plasma lipids and cardiac activity.

Authors:  S U Trost; E Swanson; B Gloss; D B Wang-Iverson; H Zhang; T Volodarsky; G J Grover; J D Baxter; G Chiellini; T S Scanlan; W H Dillmann
Journal:  Endocrinology       Date:  2000-09       Impact factor: 4.736

5.  Chemical Hybridization of Glucagon and Thyroid Hormone Optimizes Therapeutic Impact for Metabolic Disease.

Authors:  Brian Finan; Christoffer Clemmensen; Zhimeng Zhu; Kerstin Stemmer; Karine Gauthier; Luisa Müller; Meri De Angelis; Kristin Moreth; Frauke Neff; Diego Perez-Tilve; Katrin Fischer; Dominik Lutter; Miguel A Sánchez-Garrido; Peng Liu; Jan Tuckermann; Mohsen Malehmir; Marc E Healy; Achim Weber; Mathias Heikenwalder; Martin Jastroch; Maximilian Kleinert; Sigrid Jall; Sara Brandt; Frédéric Flamant; Karl-Werner Schramm; Heike Biebermann; Yvonne Döring; Christian Weber; Kirk M Habegger; Michaela Keuper; Vasily Gelfanov; Fa Liu; Josef Köhrle; Jan Rozman; Helmut Fuchs; Valerie Gailus-Durner; Martin Hrabě de Angelis; Susanna M Hofmann; Bin Yang; Matthias H Tschöp; Richard DiMarchi; Timo D Müller
Journal:  Cell       Date:  2016-10-06       Impact factor: 41.582

6.  Activation of the hepatic LDL receptor promoter by thyroid hormone.

Authors:  Dayami Lopez; Jose F Abisambra Socarrás; Mohini Bedi; Gene C Ness
Journal:  Biochim Biophys Acta       Date:  2007-05-21

7.  Physiological and Metabolic Changes During the Transition from Hyperthyroidism to Euthyroidism in Graves' Disease.

Authors:  Chiaw-Ling Chng; Adoree Yi Ying Lim; Hong Chang Tan; Jean-Paul Kovalik; Kwang Wei Tham; Yong Mong Bee; Weiying Lim; Sanchalika Acharyya; Oi Fah Lai; Mary Foong-Fong Chong; Paul Michael Yen
Journal:  Thyroid       Date:  2016-09-07       Impact factor: 6.568

Review 8.  Thyroid hormone regulation of metabolism.

Authors:  Rashmi Mullur; Yan-Yun Liu; Gregory A Brent
Journal:  Physiol Rev       Date:  2014-04       Impact factor: 37.312

9.  Thyroid hormone levels in obese children and adolescents with non-alcoholic fatty liver disease.

Authors:  Emel Torun; Ilker Tolga Özgen; Selim Gökçe; Sinem Aydın; Yaşar Cesur
Journal:  J Clin Res Pediatr Endocrinol       Date:  2014

10.  Triglyceride Mobilization from Lipid Droplets Sustains the Anti-Steatotic Action of Iodothyronines in Cultured Rat Hepatocytes.

Authors:  Elena Grasselli; Adriana Voci; Ilaria Demori; Giulia Vecchione; Andrea D Compalati; Gabriella Gallo; Fernando Goglia; Rita De Matteis; Elena Silvestri; Laura Vergani
Journal:  Front Physiol       Date:  2016-01-12       Impact factor: 4.566

View more
  105 in total

Review 1.  Autophagy as an emerging target in cardiorenal metabolic disease: From pathophysiology to management.

Authors:  Yingmei Zhang; Adam T Whaley-Connell; James R Sowers; Jun Ren
Journal:  Pharmacol Ther       Date:  2018-06-22       Impact factor: 12.310

2.  Hepatic thyroid hormone receptor β1 agonism: good for lipids, good for bile?

Authors:  Paul A Dawson; Paolo Parini
Journal:  J Lipid Res       Date:  2018-07-31       Impact factor: 5.922

Review 3.  Therapeutic pipeline in nonalcoholic steatohepatitis.

Authors:  Raj Vuppalanchi; Mazen Noureddin; Naim Alkhouri; Arun J Sanyal
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-02-10       Impact factor: 46.802

4.  Thyroid Dysfunction and Nonalcoholic Fatty Liver Disease: We Need New Larger and Well-Designed Longitudinal Studies.

Authors:  Alessandro Mantovani; Giorgio Grani
Journal:  Dig Dis Sci       Date:  2018-04-19       Impact factor: 3.199

5.  Protective role of lycopene against metabolic disorders induced by chronic bisphenol A exposure in rats.

Authors:  Rania Abdelrahman Elgawish; Marwa A El-Beltagy; Rehab M El-Sayed; Aya A Gaber; Heba M A Abdelrazek
Journal:  Environ Sci Pollut Res Int       Date:  2020-01-08       Impact factor: 4.223

6.  Thyroid and Cardiovascular Disease: Research Agenda for Enhancing Knowledge, Prevention, and Treatment.

Authors:  Anne R Cappola; Akshay S Desai; Marco Medici; Lawton S Cooper; Debra Egan; George Sopko; Glenn I Fishman; Steven Goldman; David S Cooper; Samia Mora; Peter J Kudenchuk; Anthony N Hollenberg; Cheryl L McDonald; Paul W Ladenson
Journal:  Thyroid       Date:  2019-05-13       Impact factor: 6.568

7.  Thyroid and Cardiovascular Disease Research Agenda for Enhancing Knowledge, Prevention, and Treatment.

Authors:  Anne R Cappola; Akshay S Desai; Marco Medici; Lawton S Cooper; Debra Egan; George Sopko; Glenn I Fishman; Steven Goldman; David S Cooper; Samia Mora; Peter J Kudenchuk; Anthony N Hollenberg; Cheryl L McDonald; Paul W Ladenson
Journal:  Circulation       Date:  2019-05-13       Impact factor: 29.690

8.  A Liver-Specific Thyromimetic, VK2809, Decreases Hepatosteatosis in Glycogen Storage Disease Type Ia.

Authors:  Jin Zhou; Lauren R Waskowicz; Andrea Lim; Xiao-Hui Liao; Brian Lian; Hiroko Masamune; Samuel Refetoff; Brian Tran; Dwight D Koeberl; Paul M Yen
Journal:  Thyroid       Date:  2019-08       Impact factor: 6.568

9.  Hungry for your alanine: when liver depends on muscle proteolysis.

Authors:  Theresia Sarabhai; Michael Roden
Journal:  J Clin Invest       Date:  2019-11-01       Impact factor: 14.808

Review 10.  Transcription factor GLIS3: Critical roles in thyroid hormone biosynthesis, hypothyroidism, pancreatic beta cells and diabetes.

Authors:  David W Scoville; Hong Soon Kang; Anton M Jetten
Journal:  Pharmacol Ther       Date:  2020-07-18       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.